Trial · NCT05917912
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Comparison between Treatments (ATX01 15% vs. Placebo) of mean pain attack intensity score | during the last 7 full days (Day 14 to Day 20) of each Treatment Period | Comparison between Treatments (ATX01 15% vs. Placebo) of mean pain attack intensity score assessed for the final week of each treatment period using an 11-point Numerical Pain Rating Scale (NPRS). Mean pain attack intensity is defined as the sum of the pain intensity score of each pain attack during the last 7 full days (Day 14 to Day 20) of each Treatment Period divided by the total number of erythromelalgia pain attacks during that 7-day period |
| Secondary | Mean pain attack intensity score for complete treatment period | through study completion, an average of 15 weeks | 11 point Numeric Pain Rating Scale Scale: 0-10 10 means worst possible pain |
| Secondary | Patient Global Impression of Change (PGI-C) score | through study completion, an average of 15 weeks | Patient Global Impression: Global Change (PGI-C) Scale: 1-7 7 means very much worse |
| Secondary | Change in pain interference with daily life using the Brief Pain Inventory - Short Form questionnaire (BPI-SF) | through study completion, an average of 15 weeks | Brief Pain Inventory Pain Interference Questionnaire Scale: 0-10 10 means completely interferes |
| Secondary | Change in quality of life, measured using the EuroQol-5-Dimension (EQ-5D) instrument | through study completion, an average of 15 weeks | EuroQol-5-Dimension scale |
| Secondary | Change in Beck Depression Inventory (BDI) score. | through study completion, an average of 15 weeks | BDI Scale:0-3 3 means worse |
| Secondary | Maximum pain intensity score, assessed by 11-point NPRS. | through study completion, an average of 15 weeks | 11 point Numeric Pain Rating Scale Scale: 0-10 10 means worst possible pain |
| Secondary | Mean number of pain attacks per day | through study completion, an average of 15 weeks | |
| Secondary | Mean and maximum duration of pain attacks | through study completion, an average of 15 weeks | |
| Secondary | Mean frequency of use of rescue measures (e.g., cooling). | through study completion, an average of 15 weeks | |
| Secondary | Mean duration of use of rescue measures (e.g., cooling). | through study completion, an average of 15 weeks | |
| Secondary | Change in pain score before and after rescue measures (e.g., cooling). | through study completion, an average of 15 weeks | 11 point Numeric Pain Rating Scale Scale: 0-10 10 means worst possible pain |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05917912/registered